Natera Partners With LifeLabs Medical Laboratory Services to Distribute Non-Invasive Prenatal Test Panorama(TM) in Canada

Abstract

SAN CARLOS, CALIFORNIA and TORONTO, ONTARIO--(Marketwired - Sept. 11, 2013) - Natera, a leading innovator in prenatal genetic testing, and LifeLabs Medical Laboratory Services (LifeLabs), a Canadian company with over 50 years' experience in laboratory testing and management, today announced a distribution partnership for Natera's non-invasive prenatal screening test, Panorama(TM). Panorama was launched in March 2013 for the detection of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and select sex chromosome abnormalities, such as monosomy X (Turner syndrome). The detection of triploidy was added in August 2013.